S-Amlosafe 1.25mg Tablet
By S-Amlosafe
Rx
10 Tablet in a Strip

Composition
Amlodipine(1.25mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd
Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after
September, 2025

liver
When using S-Amlosafe 1.25mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment of this medication. It is advised to consult your doctor before starting S-Amlosafe 1.25mg Tablet. In cases of liver disease, the initial dose of this medication is usually lower and then gradually increased while closely monitoring the patient's response.

kidney
S-Amlosafe 1.25mg Tablet is considered safe for use in patients with kidney disease. No dosage adjustments are needed.

alcohol
When taking S-Amlosafe 1.25mg Tablet, it is important to be cautious when consuming alcohol. It is recommended to consult your doctor regarding alcohol intake.

driving
Caution is advised while driving if you experience dizziness, headaches, nausea, or tiredness when using S-Amlosafe 1.25mg Tablet as these side effects may impair focus and reaction time.

pregnancy
S-Amlosafe 1.25mg Tablet is not recommended during pregnancy. Limited human studies suggest potential harm to the baby. Animal research also indicates risks. Your doctor will assess benefits versus risks before prescribing. Please consult your doctor.

breastfeeding
S-Amlosafe 1.25mg Tablet is likely safe during breastfeeding based on limited data. It is believed to pose no significant risk to the baby.
Habit Forming | No |
Chemical Class | Dihydropyridinecarboxylic acids derivatives |
Therapeutic Class | CARDIAC |
Action Class | Calcium channel blockers- Dihydropyridines (DHP) |
₹10.2
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024